osimertinib
astrazeneca
['osimertinib', 'lcsm,(-blcsm)', 'increase,(-increased)']
great team effort led by . an italian real world analysis of osimertinib in pts with uncommon egfr mutations. we need to increase the knowledge in this highly heterogeneous subgroup of patients #esmo22 #lcsm 
Medical Oncologist at A.O. Papardo, Messina (Italy)